FDA Approves New Alzheimer's Drug But Creators Biogen And Eisai Stock Slides
Leqembi, the first ever drug for treating the cause of Alzheimers has been approved by the FDA • Even so, the makers of the drug Biogen and Eisai have both fallen on the announcement • It follows guidance from Medicare and Medicaid in early June on how to access the drug, plus positive commentary…
#leqembi #alzheimers #fda #biogen #medicare #medicaid #eisai #valuevault #alzehimer #oxycontin